4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-053370
Director sold 10,000 shares at an average $48.53 ($485,274)
- Director acquired 10,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| DOBMEIER ERIC Director | 2020-10-01 | Option exercise | +10,000 | $6.32 | $63,200 | 10,000 | D |
| DOBMEIER ERIC Director | 2020-10-01 | Sale | −9,224 | $48.47 | $447,087 | 776 | D |
| DOBMEIER ERIC Director | 2020-10-01 | Sale | −776 | $49.21 | $38,187 | 0 | D |
| Derivatives | |||||||
| DOBMEIER ERIC Director | 2020-10-01 | Option exercise · Stock Option (Right to Buy) | −10,000 | 45,000 | D | ||
| Open-market sales · 10,000 sh · avg $48.53 · $485,274 | |||||||
Loading xslF345X03/doc4.xml…